BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that Kevin Quinlan, chief financial officer, will be presenting at the New York Society of Security Analysts (NYSSA) Biotech and Specialty Pharmaceuticals Conference on Tuesday, November 30, 2010. A live audio webcast of the 2:05 p.m. (ET) presentation may be accessed via the “Investors” section of Anika’s website at www.anikatherapeutics.com. An archive of the presentation also will be available on the website. At the conference, Mr. Quinlan will discuss the company’s business highlights, including the integration of its FAB acquisition.
